# Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism

> **NCT07530705** · PHASE1,PHASE2 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 15 (estimated)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **DRUG:** Single subcutaneous injection
- **DRUG:** Multiple subcutaneous injection

## Key facts

- **NCT ID:** NCT07530705
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-17
- **Primary completion:** 2026-05-31
- **Final completion:** 2026-06-30
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07530705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07530705, "Efficacy and Safety of Subcutaneous Injection of XH-02 in the Treatment of Adult Hypoparathyroidism". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07530705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*